Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Gastrointestinal 6Head & Neck 3Breast 2Sarcoma 1Other 1Lymphoid 1

Conditions

Obesity 298Mucositis 116Neoplasms 108Breast Neoplasms 87Overweight 80Sexual Dysfunction, Physiological 74Polycystic Ovary Syndrome 71Dyspnea 48Motor Activity 46Constipation 45Head and Neck Neoplasms 42Weight Loss 36Prostatic Neoplasms 32Pain 29Stomatitis 26Endometrial Neoplasms 23Opioid-Induced Constipation 22Multiple Endocrine Neoplasia Type 1 20Diabetes Mellitus 20Lung Neoplasms 18Colorectal Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Sexual Dysfunctions, Psychological 15Depression 15Cardiovascular Diseases 15Anxiety Disorders 15Sedentary Behavior 13Insulin Resistance 13Infertility 13Cancer-related Fatigue 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Exanthema × Other × Clear all
NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Mt. Sinai Medical Center, Miami

Phase 4 Completed
452 enrolled
Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡